# Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis

> **NCT07571460** · PHASE4 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 21 (actual)

## Conditions studied

- Liver Cirrhosis
- Portal Vein Thrombosis

## Interventions

- **DRUG:** Warfarin 3 mg
- **DRUG:** Warfarin 2 mg

## Key facts

- **NCT ID:** NCT07571460
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-15
- **Primary completion:** 2025-03-15
- **Final completion:** 2025-03-15
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07571460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07571460, "Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07571460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*